References
1. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific
ligands. Nature 346(6287):818–822
2. Wu X, Chen J, Wu M, Zhao JX (2015) Aptamers: active targeting ligands for cancer diagnosis
and therapy. Theranostics 5(4):322–344
3. Wang AZ et al (2008) Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for
combined prostate cancer imaging and therapy. ChemMedChem 3(9):1311–1315
4. Chen A, Yang S (2015) Replacing antibodies with aptamers in lateral flow immunoassay.
Biosens Bioelectron 71:230–242
5. Ferreira CDA, De Barros ALB (2013) Aptamer functionalized nanoparticles for cancer
targeting. J Mol Pharm Org Process Res 01(02):1–2
6. Modrejewski J et al (2016) Aptamer-modified polymer nanoparticles for targeted drug delivery. BioNanoMaterials 17(1–2):43–51
7. Luo YL, Shiao YS, Huang YF (2011) Release of photoactivatable drugs from plasmonic
nanoparticles for targeted cancer therapy. ACS Nano 5(10):7796–7804
8. Zhu Z et al (2008) Regulation of singlet oxygen generation using single-walled carbon
nanotubes. J Am Chem Soc 130:10856–10857
9. Min K et al (2011) Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and
PSMA (À) prostate cancers. Biomaterials 32(8):2124–2132
10. Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9
(7):537–550
11. Patel DJ et al (1997) Structure, recognition and adaptive binding in RNA aptamer complexes. J
Mol Biol 272(5):645–664
12. Urmann K, Modrejewski J, Scheper T, Walter J-G (2017) Aptamer-modified nanomaterials:
principles and applications. BioNanoMaterials 18(1–2):1–17
13. Walter JG, Kökpinar Ö, Friehs K, Stahl F, Scheper T (2008) Systematic investigation of
optimal aptamer immobilization for protein-microarray applications. Anal Chem 80
(19):7372–7378
14. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Banaszak Holl MM (2007) The binding
avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14
(1):107–115
15. Vorobyeva M, Vorobjev P, Venyaminova A (2016) Multivalent aptamers: versatile tools for
diagnostic and therapeutic applications. Molecules 21(12):1613
16. Li H et al (2015) Multifunctional aptamer-silver conjugates as theragnostic agents for specific
cancer cell therapy and fluorescence-enhanced cell imaging. Anal Chem 87(7):3736–3745
17. Stephanopoulos N, Tong GJ, Hsiao SC, Francis MB (2010) Dual-surface modified virus
capsids for targeted delivery of photodynamic agents to cancer cells. ACS Nano 4
(10):6014–6020
18. Hsu CL, Chang HT, Chen CT, Wei SC, Shiang YC, Huang CC (2011) Highly efficient control
of thrombin activity by multivalent nanoparticles. Chem Eur J 17(39):10994–11000
19. Huang SS, Wei SC, Chang HT, Lin HJ, Huang CC (2016) Gold nanoparticles modified with
self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant. J
Control Release 221:9–17
20. Zhang G, Zhu C, Huang Y, Yan J, Chen A (2018) A lateral flow strip based aptasensor for
detection of Ochratoxin a in corn samples. Molecules 23(2):1–12
21. Wang P et al (2016) Aptamer-wrapped gold nanoparticles for the colorimetric detection of
omethoate. Sci China Chem 59(2):237–242
22. Mohamad A, Teo H, Keasberry NA, Ahmed MU (2019) Recent developments in colorimetric
immunoassays using nanozymes and plasmonic nanoparticles. Crit Rev Biotechnol 39
(1):50–66
23. Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in
diagnostics. Clin Chem 45:1628–1650
188
A. Eilers et al.
1. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific
ligands. Nature 346(6287):818–822
2. Wu X, Chen J, Wu M, Zhao JX (2015) Aptamers: active targeting ligands for cancer diagnosis
and therapy. Theranostics 5(4):322–344
3. Wang AZ et al (2008) Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for
combined prostate cancer imaging and therapy. ChemMedChem 3(9):1311–1315
4. Chen A, Yang S (2015) Replacing antibodies with aptamers in lateral flow immunoassay.
Biosens Bioelectron 71:230–242
5. Ferreira CDA, De Barros ALB (2013) Aptamer functionalized nanoparticles for cancer
targeting. J Mol Pharm Org Process Res 01(02):1–2
6. Modrejewski J et al (2016) Aptamer-modified polymer nanoparticles for targeted drug delivery. BioNanoMaterials 17(1–2):43–51
7. Luo YL, Shiao YS, Huang YF (2011) Release of photoactivatable drugs from plasmonic
nanoparticles for targeted cancer therapy. ACS Nano 5(10):7796–7804
8. Zhu Z et al (2008) Regulation of singlet oxygen generation using single-walled carbon
nanotubes. J Am Chem Soc 130:10856–10857
9. Min K et al (2011) Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and
PSMA (À) prostate cancers. Biomaterials 32(8):2124–2132
10. Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9
(7):537–550
11. Patel DJ et al (1997) Structure, recognition and adaptive binding in RNA aptamer complexes. J
Mol Biol 272(5):645–664
12. Urmann K, Modrejewski J, Scheper T, Walter J-G (2017) Aptamer-modified nanomaterials:
principles and applications. BioNanoMaterials 18(1–2):1–17
13. Walter JG, Kökpinar Ö, Friehs K, Stahl F, Scheper T (2008) Systematic investigation of
optimal aptamer immobilization for protein-microarray applications. Anal Chem 80
(19):7372–7378
14. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Banaszak Holl MM (2007) The binding
avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14
(1):107–115
15. Vorobyeva M, Vorobjev P, Venyaminova A (2016) Multivalent aptamers: versatile tools for
diagnostic and therapeutic applications. Molecules 21(12):1613
16. Li H et al (2015) Multifunctional aptamer-silver conjugates as theragnostic agents for specific
cancer cell therapy and fluorescence-enhanced cell imaging. Anal Chem 87(7):3736–3745
17. Stephanopoulos N, Tong GJ, Hsiao SC, Francis MB (2010) Dual-surface modified virus
capsids for targeted delivery of photodynamic agents to cancer cells. ACS Nano 4
(10):6014–6020
18. Hsu CL, Chang HT, Chen CT, Wei SC, Shiang YC, Huang CC (2011) Highly efficient control
of thrombin activity by multivalent nanoparticles. Chem Eur J 17(39):10994–11000
19. Huang SS, Wei SC, Chang HT, Lin HJ, Huang CC (2016) Gold nanoparticles modified with
self-assembled hybrid monolayer of triblock aptamers as a photoreversible anticoagulant. J
Control Release 221:9–17
20. Zhang G, Zhu C, Huang Y, Yan J, Chen A (2018) A lateral flow strip based aptasensor for
detection of Ochratoxin a in corn samples. Molecules 23(2):1–12
21. Wang P et al (2016) Aptamer-wrapped gold nanoparticles for the colorimetric detection of
omethoate. Sci China Chem 59(2):237–242
22. Mohamad A, Teo H, Keasberry NA, Ahmed MU (2019) Recent developments in colorimetric
immunoassays using nanozymes and plasmonic nanoparticles. Crit Rev Biotechnol 39
(1):50–66
23. Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in
diagnostics. Clin Chem 45:1628–1650
188
A. Eilers et al.